Glycans-by-design: Engineering bacteria for the biosynthesis of complex glycans and glycoconjugates

Biotechnology and Bioengineering

Volumn 110, Issue 6, 2013, Pages 1550-1564

  Merritt, Judith H ^a   Ollis, Anne A ^b   Fisher, Adam C ^a   Delisa, Matthew P ^b  

^a Glycobia Inc   (United States)

^b School of Operations Research and Industrial Engineering   (United States)

Author keywords

Escherichia coli; Glycoengineering; Glycolipids; Glycome; Glycoproteins; Glycosylation; Glycosyltransferase; Lipopolysaccharides; Oligosaccharyltransferase; Sugar nucleotides

Indexed keywords

GLYCOENGINEERING; GLYCOLIPIDS; GLYCOME; GLYCOSYL TRANSFERASE; LIPOPOLYSACCHARIDES; OLIGOSACCHARYLTRANSFERASE; SUGAR NUCLEOTIDES;

BACTERIA; BIOSYNTHESIS; DESIGN; ESCHERICHIA COLI; ESTERIFICATION; GLYCOPROTEINS; GLYCOSYLATION; LIPIDS;

POLYSACCHARIDES;

GLYCAN; GLYCOCONJUGATE; GLYCOLIPID; LIPID; PROTEIN;

BACTERIAL GLYCOENGINEERING; BACTERIUM TRANSFORMATION; BIOSYNTHESIS; ENGINEERING; NONHUMAN; PROTEIN GLYCOSYLATION; REVIEW;

BACTERIA; ESCHERICHIA COLI; GLYCOCONJUGATES; GLYCOSYLATION; METABOLIC ENGINEERING; POLYSACCHARIDES;

ESCHERICHIA COLI; HARNESS;

EID: 84876769057     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24885     Document Type: Review

References (103)

1. Aas FE, Vik A, Vedde J, Koomey M, Egge-Jacobsen W. 2007. Neisseria gonorrhoeae O-linked pilin glycosylation: Functional analyses define both the biosynthetic pathway and glycan structure. Mol Microbiol 65(3): 607-624.
2. Abu Kwaik Y, McLaughlin R, Apicella M, Spinola S. 1991. Analysis of Haemophilus influenzae type b lipooligosaccharide-synthesis genes that assemble or expose a 2-keto-3-deoxyoctulosonic acid epitope. Mol Microbiol 5(10): 2475-2480.
3. Andrianopoulos K, Wang L, Reeves PR. 1998. Identification of the fucose synthetase gene in the colanic acid gene cluster of Escherichia coli K-12. J Bacteriol 180(4): 998-1001.
4. Angström J, Teneberg S, Karlsson KA. 1994. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: Evidence for overlapping epitopes. Proc Natl Acad Sci USA 91(25): 11859-11863.
5. Ångström J, Bäckström M, Berntsson A, Karlsson N, Holmgren J, Karlsson K-A, Lebens M, Teneberg S. 2000. Novel carbohydrate binding site recognizing blood group A and B determinants in a hybrid of cholera toxin and Escherichia coli heat-labile enterotoxin B-subunits. J Biol Chem 275(5): 3231-3238.
6. Antoine T, Priem B, Heyraud A, Greffe L, Gilbert M, Wakarchuk WW, Lam JS, Samain E. 2003. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. Chembiochem 4(5): 406-412.
7. Antoine T, Bosso C, Heyraud A, Samain E. 2005. Large scale in vivo synthesis of globotriose and globotetraose by high cell density culture of metabolically engineered Escherichia coli. Biochimie 87(2): 197-203.
8. Celik E, Fisher AC, Guarino C, Mansell TJ, DeLisa MP. 2010. A filamentous phage display system for N-linked glycoproteins. Protein Sci 19: 2006-2013.
9. Cottaz S, Samain E. 2005. Genetic engineering of Escherichia coli for the production of NI, NII-diacetylchitobiose (chitinbiose) and its utilization as a primer for the synthesis of complex carbohydrates. Metab Eng 7(4): 311-317.
10. Dell A, Galadari A, Sastre F, Hitchen P. 2010. Similarities and differences in the glycosylation mechanisms in prokaryotes and eukaryotes. Int J Microbiol 2010: 148178.
11. Domenico P, Salo RJ, Cross AS, Cunha BA. 1994. Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect Immun 62(10): 4495-4499.
12. Dumon C, Priem B, Martin SL, Heyraud A, Bosso C, Samain E. 2001. In vivo fucosylation of lacto-N-neotetraose and lacto-N-neohexaose by heterologous expression of Helicobacter pylori alpha-1, 3 fucosyltransferase in engineered Escherichia coli. Glycoconj J 18(6): 465-474.
13. Dumon C, Bosso C, Utille JP, Heyraud A, Samain E. 2006. Production of Lewis x tetrasaccharides by metabolically engineered Escherichia coli. Chembiochem 7(2): 359-365.
14. Durr C, Nothaft H, Lizak C, Glockshuber R, Aebi M. 2010. The Escherichia coli glycophage display system. Glycobiology 20(11): 1366-1372.
15. Egge-Jacobsen W, Salomonsson EN, Aas FE, Forslund AL, Winther-Larsen HC, Maier J, Macellaro A, Kuoppa K, Oyston PC, Titball RW, Thomas RM, Forsberg Å, Prior JL, Koomey M. 2011. O-linked glycosylation of the PilA pilin protein of Francisella tularensis: Identification of the endogenous protein-targeting oligosaccharyltransferase and characterization of the native oligosaccharide. J Bacteriol 193(19): 5487-5497.
16. Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, Buck L, Busse L, Chang D, Fuller J, Grant J, et al. 2003. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 21(4): 414-421.
17. Faridmoayer A, Fentabil MA, Mills DC, Klassen JS, Feldman MF. 2007. Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation. J Bacteriol 189(22): 8088-8098.
18. Faridmoayer A, Fentabil MA, Haurat MF, Yi W, Woodward R, Wang PG, Feldman MF. 2008. Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O-glycosylation. J Biol Chem 283(50): 34596-34604.
19. Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, Kowarik M, Morris HR, Dell A, Valvano MA, Aebi M. 2005. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci U S A 102(8): 3016-3021.
20. Fisher AC, Haitjema CH, Guarino C, Celik E, Endicott CE, Reading CA, Merritt JH, Ptak AC, Zhang S, DeLisa MP. 2011. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl Environ Microbiol 77(3): 871-881.
21. Focareta A, Paton JC, Morona R, Cook J, Paton AW. 2006. A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 130(6): 1688-1695.
22. Friedman B, Vaddi K, Preston C, Mahon E, Cataldo JR, McPherson JM. 1999. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: Implications for clinical efficacy in treatment of Gaucher disease. Blood 93(9): 2807-2816.
23. Gabius HJ. 2000. Biological information transfer beyond the genetic code: The sugar code. Naturwissenschaften 87(3): 108-121.
24. Gebhart C, Ielmini MV, Reiz B, Price NL, Aas FE, Koomey M, Feldman MF. 2012. Characterization of exogenous bacterial oligosaccharyltransferases in Escherichia coli reveals the potential for O-linked protein glycosylation in Vibrio cholerae and Burkholderia thailandensis. Glycobiology 22(7): 962-974.
25. Gupta G, Surolia A, Sampathkumar SG. 2010. Lectin microarrays for glycomic analysis. OMICS 14(4): 419-436.
26. Heinrichs DE, Yethon JA, Amor PA, Whitfield C. 1998. The assembly system for the outer core portion of R1- and R4-type lipopolysaccharides of Escherichia coli. J Biol Chem 273(45): 29497-29505.
27. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science 291(5512): 2364-2369.
28. Helenius A, Aebi M. 2004. Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73: 1019-1049.
29. Henderson GE, Isett KD, Gerngross TU. 2011. Site-specific modification of recombinant proteins: A novel platform for modifying glycoproteins expressed in E. coli. Bioconjug Chem 22(5): 903-912.
30. Hitchen PG, Dell A. 2006. Bacterial glycoproteomics. Microbiology 152(6): 1575-1580.
31. Hug I, Feldman MF. 2011. Analogies and homologies in lipopolysaccharide and glycoprotein biosynthesis in bacteria. Glycobiology 21(2): 138-151.
32. Hug I, Zheng B, Reiz B, Whittal RM, Fentabil MA, Klassen JS, Feldman MF. 2011. Exploiting bacterial glycosylation machineries for the synthesis of a Lewis antigen-containing glycoprotein. J Biol Chem 286(43): 37887-37894.
33. Ielmini MV, Feldman MF. 2011. Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements. Glycobiology 21(6): 734-742.
34. Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thony-Meyer L. 2010. Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact 9: 61.
35. Ihssen J, Kowarik M, Wiesli L, Reiss R, Wacker M, Thony-Meyer L. 2012. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB. BMC Biotechnol 12(1): 67.
36. Ilg K, Yavuz E, Maffioli C, Priem B, Aebi M. 2010. Glycomimicry: Display of the GM3 sugar epitope on Escherichia coli and Salmonella enterica sv Typhimurium. Glycobiology 20(10): 1289-1297.
37. Iwashkiw JA, Fentabil MA, Faridmoayer A, Mills DC, Peppler M, Czibener C, Ciocchini AE, Comerci DJ, Ugalde JE, Feldman MF. 2012a. Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis. Microb Cell Fact 11: 13.
38. Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov E, Stratilo C, Reiz B, Cordwell SJ, Whittal R, Schild S, et al. 2012b. Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog 8(6): e1002758.
39. Jervis AJ, Langdon R, Hitchen P, Lawson AJ, Wood A, Fothergill JL, Morris HR, Dell A, Wren B, Linton D. 2010. Characterization of N-linked protein glycosylation in Helicobacter pullorum. J Bacteriol 192(19): 5228-5236.
40. Jervis AJ, Butler JA, Lawson AJ, Langdon R, Wren BW, Linton D. 2012. Characterization of the structurally diverse N-linked glycans of Campylobacter species. J Bacteriol 194(9): 2355-2362.
41. Knauer R, Lehle L. 1999. The oligosaccharyltransferase complex from yeast. Biochim Biophys Acta 1426(2): 259-273.
42. Kowarik M, Young NM, Numao S, Schulz BL, Hug I, Callewaert N, Mills DC, Watson DC, Hernandez M, Kelly JF, et al. 2006. Definition of the bacterial N-glycosylation site consensus sequence. EMBO J 25(9): 1957-1966.
43. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. 2001. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414(6863): 555-558.
44. Ku SC, Schulz BL, Power PM, Jennings MP. 2009. The pilin O-glycosylation pathway of pathogenic Neisseria is a general system that glycosylates AniA, an outer membrane nitrite reductase. Biochem Biophys Res Commun 378(1): 84-89.
45. Kuhn H-M, Meier-Dieter U, Mayer H. 1988. ECA, the enterobacterial common antigen*. FEMS Microbiol Rev 54(3): 195-222.
46. LaTemple DC, Abrams JT, Zhang SY, Galili U. 1999. Increased immunogenicity of tumor vaccines complexed with anti-Gal: Studies in knockout mice for alpha1, 3galactosyltransferase. Cancer Res 59(14): 3417-3423.
47. Lingwood CA. 1996. Role of verotoxin receptors in pathogenesis. Trends Microbiol 4(4): 147-153.
48. Linton D, Allan E, Karlyshev AV, Cronshaw AD, Wren BW. 2002. Identification of N-acetylgalactosamine-containing glycoproteins PEB3 and CgpA in Campylobacter jejuni. Mol Microbiol 43(2): 497-508.
49. Liu L, Xu YX, Hirschberg CB. 2010. The role of nucleotide sugar transporters in development of eukaryotes. Semin Cell Dev Biol 21(6): 600-608.
50. Lizak C, Fan YY, Weber TC, Aebi M. 2011a. N-Linked glycosylation of antibody fragments in Escherichia coli. Bioconjug Chem 22(3): 488-496.
51. Lizak C, Gerber S, Numao S, Aebi M, Locher KP. 2011b. X-ray structure of a bacterial oligosaccharyltransferase. Nature 474(7351): 350-355.
52. Lundborg M, Modhukur V, Widmalm G. 2010. Glycosyltransferase functions of E. coli O-antigens. Glycobiology 20(3): 366-368.
53. Macdougall IC. 2002. Optimizing the use of erythropoietic agents- pharmacokinetic and pharmacodynamic considerations. Nephrol Dial Transplant 5: 66-70.
54. Mally M, Fontana C, Leibundgut-Landmann S, Laacisse L, Fan YY, Widmalm G, Aebi M. 2012. Glycoengineering of host mimicking type-2 LacNAc polymers and Lewis X antigens on bacterial cell surfaces. Mol Microbiol 87: 112-131. DOI: 10.1111/mmi.12086.
55. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1): 107-118.
56. Moran AP, Appelmelk BJ, Aspinall GO. 1996. Review: Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: Implications in pathogenesis. J Endotoxin Res 3(6): 521-531.
57. Nothaft H, Szymanski CM. 2010. Protein glycosylation in bacteria: Sweeter than ever. Nat Rev Microbiol 8(11): 765-778.
58. Nothaft H, Liu X, McNally DJ, Li J, Szymanski CM. 2009. Study of free oligosaccharides derived from the bacterial N-glycosylation pathway. Proc Natl Acad Sci USA 106(35): 15019-15024.
59. O'Riordan K, Lee JC. 2004. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 17(1): 218-234.
60. Orskov I, Orskov F, Jann B, Jann K. 1977. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev 41(3): 667-710.
61. Pandhal J, Ow SY, Noirel J, Wright PC. 2011. Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring. Biotechnol Bioeng 108(4): 902-912.
62. Pandhal J, Desai P, Walpole C, Doroudi L, Malyshev D, Wright PC. 2012. Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli. Biochem Biophys Res Commun 419(3): 472-476.
63. Paton AW, Paton JC. 1999. Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113. Infect Immun 67(11): 5930-5937.
64. Paton AW, Morona R, Paton JC. 2000. A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat Med 6(3): 265-270.
65. Paton AW, Morona R, Paton JC. 2001. Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose. Infect Immun 69(3): 1967-1970.
66. Paton AW, Jennings MP, Morona R, Wang H, Focareta A, Roddam LF, Paton JC. 2005. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 128(5): 1219-1228.
67. Perugino G, Trincone A, Rossi M, Moracci M. 2004. Oligosaccharide synthesis by glycosynthases. Trends Biotechnol 22(1): 31-37.
68. Phillips NJ, Miller TJ, Engstrom JJ, Melaugh W, McLaughlin R, Apicella MA, Gibson BW. 2000. Characterization of chimeric lipopolysaccharides from Escherichia coli strain JM109 transformed with lipooligosaccharide synthesis genes (lsg) from Haemophilus influenzae. J Biol Chem 275(7): 4747-4758.
69. Priem B, Gilbert M, Wakarchuk WW, Heyraud A, Samain E. 2002. A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. Glycobiology 12(4): 235-240.
70. Raetz CRH, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700.
71. Rothman RJ, Perussia B, Herlyn D, Warren L. 1989. Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation. Mol Immunol 26(12): 1113-1123.
72. Ruffing A, Chen RR. 2006. Metabolic engineering of microbes for oligosaccharide and polysaccharide synthesis. Microb Cell Fact 5: 25.
73. Ruiz N, Kahne D, Silhavy TJ. 2009. Transport of lipopolysaccharide across the cell envelope: The long road of discovery. Nat Rev Microbiol 7(9): 677-683.
74. Samuel G, Reeves P. 2003. Biosynthesis of O-antigens: Genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr Res 338(23): 2503-2519.
75. Schiller JG, Lamy F, Frazier R, Feingold DS. 1976. UDP-glucose dehydrogenase from Escherichia coli. Purification and subunit structure. Biochim Biophys Acta 453(2): 418-425.
76. Schwarz F, Aebi M. 2011. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol 21(5): 576-582.
77. Schwarz F, Huang W, Li C, Schulz BL, Lizak C, Palumbo A, Numao S, Neri D, Aebi M, Wang LX. 2010. A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation. Nat Chem Biol 6(4): 264-266.
78. Schwarz F, Fan YY, Schubert M, Aebi M. 2011a. Cytoplasmic N-glycosyltransferase of Actinobacillus pleuropneumoniae is an inverting enzyme and recognizes the NX(S/T) consensus sequence. J Biol Chem 286(40): 35267-35274.
79. Schwarz F, Lizak C, Fan YY, Fleurkens S, Kowarik M, Aebi M. 2011b. Relaxed acceptor site specificity of bacterial oligosaccharyltransferase in vivo. Glycobiology 21(1): 45-54.
80. Sethuraman N, Stadheim TA. 2006. Challenges in therapeutic glycoprotein production. Curr Opin Biotechnol 17(4): 341-346.
81. Severi E, Hood DW, Thomas GH. 2007. Sialic acid utilization by bacterial pathogens. Microbiology 153(9): 2817-2822.
82. Sleytr UB. 1975. Heterologous reattachment of regular arrays of glycoproteins on bacterial surfaces. Nature 257(5525): 400-402.
83. Stenutz R, Weintraub A, Widmalm G. 2006. The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30(3): 382-403.
84. Stevenson G, Neal B, Liu D, Hobbs M, Packer NH, Batley M, Redmond JW, Lindquist L, Reeves P. 1994. Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. J Bacteriol 176(13): 4144-4156.
85. Stevenson G, Andrianopoulos K, Hobbs M, Reeves PR. 1996. Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J Bacteriol 178(16): 4885-4893.
86. Szymanski CM, Yao R, Ewing CP, Trust TJ, Guerry P. 1999. Evidence for a system of general protein glycosylation in Campylobacter jejuni. Mol Microbiol 32(5): 1022-1030.
87. Tiralongo J, Maggioni A. 2011. The targeted expression of nucleotide sugar transporters to the E. coli inner membrane. Methods Mol Biol 705: 237-249.
88. Tsai CM. 2001. Molecular mimicry of host structures by lipooligosaccharides of Neisseria meningitidis: Characterization of sialylated and nonsialylated lacto-N-neotetraose (Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc) structures in lipooligosaccharides using monoclonal antibodies and specific lectins. Adv Exp Med Biol 491: 525-542.
89. Turnbull JE, Field RA. 2007. Emerging glycomics technologies. Nat Chem Biol 3(2): 74-77.
90. Valderrama-Rincon JD, Fisher AC, Merritt JH, Fan YY, Reading CA, Chhiba K, Heiss C, Azadi P, Aebi M, Delisa MP. 2012. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol 8(5): 434-436.
91. Varki A. 1993. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3(2): 97-130.
92. Vik A, Aas FE, Anonsen JH, Bilsborough S, Schneider A, Egge-Jacobsen W, Koomey M. 2009. Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc Natl Acad Sci USA 106(11): 4447-4452.
93. Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, Panico M, Morris HR, Dell A, Wren BW, et al. 2002. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 298(5599): 1790-1793.
94. Walt D, Aoki-Kinoshita KF, Bendiak B, Bertozzi CR, Boons G-J, Darvill A, Hart G, Kiessling LL, Lowe J, Moon RJ, National Research Council. 2012. Transforming glycoscience: A roadmap for the future. Washington, DC: The National Academies Press.
95. Wang X, Quinn PJ. 2010. Lipopolysaccharide: Biosynthetic pathway and structure modification. Prog Lipid Res 49(2): 97-107.
96. Weerapana E, Imperiali B. 2006. Asparagine-linked protein glycosylation: From eukaryotic to prokaryotic systems. Glycobiology 16(6): 91R-101R.
97. Whitfield C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75(1): 39-68.
98. Yan Q, Lennarz WJ. 2002a. Studies on the function of oligosaccharyl transferase subunits: A glycosylatable photoprobe binds to the luminal domain of Ost1p. Proc Natl Acad Sci USA 99(25): 15994-15999.
99. Yan Q, Lennarz WJ. 2002b. Studies on the function of oligosaccharyl transferase subunits. Stt3p is directly involved in the glycosylation process. J Biol Chem 277(49): 47692-47700.
100. Yavuz E, Drouillard S, Samain E, Roberts I, Priem B. 2008. Glucuronylation in Escherichia coli for the bacterial synthesis of the carbohydrate moiety of nonsulfated HNK-1. Glycobiology 18(2): 152-157.
101. Yavuz E, Maffioli C, Ilg K, Aebi M, Priem B. 2011. Glycomimicry: Display of fucosylation on the lipo-oligosaccharide of recombinant Escherichia coli K12. Glycoconj J 28(1): 39-47.
102. Young NM, Brisson JR, Kelly J, Watson DC, Tessier L, Lanthier PH, Jarrell HC, Cadotte N, St Michael F, Aberg E, et al. 2002. Structure of the N-linked glycan present on multiple glycoproteins in the Gram-negative bacterium, Campylobacter jejuni. J Biol Chem 277(45): 42530-42539.
103. Zarschler K, Janesch B, Pabst M, Altmann F, Messner P, Schaffer C. 2010. Protein tyrosine O-glycosylation-a rather unexplored prokaryotic glycosylation system. Glycobiology 20(6): 787-798.